Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human telomeric G-quadruplex DNA is a non-canonical secondary structure formed by the guanine-rich tandem repeats (TTAGGG) at the ends of human chromosomes [6, 7]. These structures are composed of stacked G-tetrads stabilized by Hoogsteen hydrogen bonds and monovalent cations, typically potassium or sodium [1, 6]. In most cancer cells, telomere length is maintained by the overexpressed enzyme telomerase, which prevents the natural senescence that occurs in somatic cells [3, 12]. Small molecule ligands designed to target and stabilize these G-quadruplexes can physically block telomerase access and displace protective shelterin proteins like POT1 [2, 13]. This uncapping of the telomere is recognized by the cell as a double-strand break, triggering a robust DNA damage response that leads to apoptosis or permanent growth arrest [2, 10]. As such, the human telomeric G-quadruplex represents a promising therapeutic target for broad-spectrum anticancer drug development [4, 8].
Stabilization of the G-quadruplex structure at the 3' telomeric overhang, which inhibits telomerase-mediated telomere extension and displaces telomere-binding proteins such as POT1, leading to telomere uncapping, activation of the DNA damage response, and subsequent induction of apoptosis or senescence [2, 6, 10].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human telomeric G-quadruplex DNA (hTel G4).